Publication:
Potential Impact of Atelectasis and Primary Tumor Glycolysis on F-18 FDG PET/CT on Survival in Lung Cancer Patients

dc.contributor.authorsHasbek, Zekiye; Yucel, Birsen; Salk, Ismail; Turgut, Bulent; Erselcan, Taner; Babacan, Nalan Akgul; Kacan, Turgut
dc.date.accessioned2022-03-14T10:20:01Z
dc.date.accessioned2026-01-11T13:55:07Z
dc.date.available2022-03-14T10:20:01Z
dc.date.issued2014-05-15
dc.description.abstractBackground: Atelectasis is an important prognostic factor that can cause pleuritic chest pain, coughing or dyspnea, and even may be a cause of death. In this study, we aimed to investigate the potential impact of atelectasis and PET parameters on survival and the relation between atelectasis and PET parameters. Materials and Methods: The study consisted of patients with lung cancer with or without atelectasis who underwent F-18-FDG PET/CT examination before receiving any treatment. F-18-FDG PET/CT derived parameters including tumor size, SUVmax, SUVmean, MTV, total lesion glycosis (TLG), SUV mean of atelectasis area, atelectasis volume, and histological and TNM stage were considered as potential prognostic factors for overall survival. Results: Fifty consecutive lung cancer patients (22 patients with atelectasis and 28 patients without atelectasis, median age of 65 years) were evaluated in the present study. There was no relationship between tumor size and presence or absence of atelectasis, nor between presence/absence of atelectasis and TLG of primary tumors. The overall one-year survival rate was 83% and median survival was 20 months (n=22) in the presence of atelectasis; the overall one-year survival rate was 65.7% (n=28) and median survival was 16 months (p=0.138) in the absence of atelectasis. With respect to PFS; the one-year survival rate of AT+ patients was 81.8% and median survival was 19 months; the one-year survival rate of AT- patients was 64.3% and median survival was 16 months (p=0.159). According to univariate analysis, MTV, TLG and tumor size were significant risk factors for PFS and OS (p<0.05). However, SUVmax was not a significant factor for PFS and OS (p>0.05). Conclusions: The present study suggested that total lesion glycolysis and metabolic tumor volume were important predictors of survival in lung cancer patients, in contrast to SUVmax. In addition, having a segmental lung atelectasis seems not to be a significant factor on survival.
dc.identifier.doi10.7314/APJCP.2014.15.9.4085
dc.identifier.issn1513-7368
dc.identifier.pubmed24935601
dc.identifier.urihttps://hdl.handle.net/11424/244356
dc.identifier.wosWOS:000338634000041
dc.language.isoeng
dc.publisherASIAN PACIFIC ORGANIZATION CANCER PREVENTION
dc.relation.ispartofASIAN PACIFIC JOURNAL OF CANCER PREVENTION
dc.rightsinfo:eu-repo/semantics/openAccess
dc.subjectAtelectasis
dc.subjectlung cancer
dc.subjectF-18-FDG
dc.subjectPET/CT
dc.subjecttotal lesion glycolysis
dc.subjectTOTAL LESION GLYCOLYSIS
dc.subjectPROGNOSTIC-SIGNIFICANCE
dc.subject18F-FDG PET/CT
dc.subjectCARCINOMA
dc.subjectVOLUME
dc.subjectCT
dc.subjectRADIOTHERAPY
dc.subjectTHERAPY
dc.subjectBURDEN
dc.titlePotential Impact of Atelectasis and Primary Tumor Glycolysis on F-18 FDG PET/CT on Survival in Lung Cancer Patients
dc.typearticle
dspace.entity.typePublication
oaire.citation.endPage4089
oaire.citation.issue9
oaire.citation.startPage4085
oaire.citation.titleASIAN PACIFIC JOURNAL OF CANCER PREVENTION
oaire.citation.volume15

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
file.pdf
Size:
697.17 KB
Format:
Adobe Portable Document Format